4//SEC Filing
ALEXION PHARMACEUTICALS INC 4
Accession 0000899866-17-000053
CIK 0000899866operating
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 7:44 PM ET
Size
6.9 KB
Accession
0000899866-17-000053
Insider Transaction Report
Form 4
BELL LEONARD
DirectorCEO
Transactions
- Sale
Common Stock, par value $.0001 per share
2017-02-28$131.71/sh−2,738$360,622→ 391,910 total - Sale
Common Stock, par value $.0001 per share
2017-03-01$132.50/sh−1,240$164,300→ 390,670 total
Footnotes (3)
- [F1]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $131.00 - $131.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $132.00 - $132.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000899866
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 7:44 PM ET
- Size
- 6.9 KB